Dexmedetomidine Improves Cognitive Disfunction in Elderly Rats induced by Scopolamine

Jun-ru YIN,Long-fei GAO,Bin-rong WANG,Yong-hui YANG,Chang-jun GAO,Xu-de SUN
DOI: https://doi.org/10.13241/j.cnki.pmb.2017.31.004
2017-01-01
Abstract:Objective:To observe the effect of Dexmedetomidine on cognitive disfunction in elderly rats induced by scopolamine and explore its functionary mechanism.Methods:The male SD rats,20-month-old,were randomly divided into 3 groups (Sco group),Scopolamine + Dexamethidine group (Dex group) and Control group (Con group),rats were given scopolamine 0.8 mg/kg in Sco group,rats were given scopolamine 0.8 mg/kg + dexmedetomidine 20 μg/kg in Dex group,rats were given the same volume of saline in Con group.Morris water maze was performed on rats 2 h after administration.The oxidative reaction in the hippocampus was measured after the test.The indexes were selected as SOD and MDA,and the content of TNF-α and IL-1β in hippocampus was determined by enzyme-linked immunosorbent assay (ELISA).Results:Compared with Sco group,the escape latency of the rats in the Dex group was significantly decreased and the exploration time of the plateau region was significantly increased.Compared with the Sco group the content of SOD in the hippocampus of rats was significantly increased after dexmedetomidine treatment,and the levels of TNF-α and IL-1β were reduced.Conclusion:Dexmedetomidine can effectively reduce the cognitive impairment in elderly rats induced by scopolamine and its mechanism may involve the anti-oxidative stress and anti-inflammatory response of dexmedetomidine in the hippocampus of rats.
What problem does this paper attempt to address?